Nottingham, United Kingdom

Jokin Carrillo Arregui

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Nimbus Clio, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jokin Carrillo Arregui. Retrieved from https://idiyas.com/inventor/jokin-carrillo-arregui-59s75qb4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jokin Carrillo Arregui: Innovator in Cbl-b Modulation

Introduction

Jokin Carrillo Arregui is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of biotechnology, particularly in the modulation of Cbl-b, a protein involved in immune regulation.

Latest Patents

His most recent patent, titled "CBL-B modulators and uses thereof," focuses on compounds and compositions that inhibit Cbl-b. This invention provides methods for treating disorders mediated by Cbl-b, showcasing his innovative approach to addressing complex biological challenges. Jokin holds 1 patent in this area.

Career Highlights

Jokin Carrillo Arregui is associated with Nimbus Clio, Inc., where he continues to advance his research and development efforts. His work is pivotal in exploring new therapeutic avenues for diseases linked to immune system dysfunction.

Collaborations

Throughout his career, Jokin has collaborated with esteemed colleagues, including Silvana Marcel Leit De Moradei and Angela V West. These partnerships have enriched his research and contributed to the advancement of their shared goals in biotechnology.

Conclusion

Jokin Carrillo Arregui stands out as an innovative inventor in the field of Cbl-b modulation, with a focus on developing therapeutic solutions for immune-related disorders. His contributions are paving the way for future advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…